The cost of relapse and the predictors of relapse in the treatment of schizophrenia, BMC Psychiatry, vol.10, issue.2, 2011. ,
Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder, Arch Gen Psychiatry, vol.56, pp.241-247, 1999. ,
Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort, Schizophr Bull, vol.24, pp.75-85, 1998. ,
The burden of schizophrenia on caregivers: a review, Pharmacoeconomics, vol.26, pp.149-162, 2008. ,
Relapse in schizophrenia: costs, clinical outcomes and quality of life, Br J Psychiatry, vol.184, pp.346-351, 2004. ,
The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study, Prog Neuropsychopharmacol Biol Psychiatry, vol.33, pp.835-841, 2009. ,
Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia, Am J Psychiatry, vol.161, pp.692-699, 2004. ,
Factors influencing relapse in the long-term course of schizophrenia, Schizophr Res, vol.28, pp.199-206, 1997. ,
Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapy, J Psychiatr Res, vol.41, pp.305-310, 2007. ,
, Lancet, vol.374, pp.635-645, 2009.
Review: the wider social environment and schizophrenia, Schizophr Bull, vol.32, pp.592-598, 2006. ,
The World Health Organization WHOQOL-100: tests of the universality of Quality of Life in 15 different cultural groups worldwide, Health Psychol, vol.18, pp.495-505, 1999. ,
Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis, J Am Soc Nephrol, vol.12, pp.2797-2806, 2001. ,
Predictive validity of short-form health survey [36 items] scales for chronic obstructive pulmonary disease exacerbation, Heart Lung, vol.37, pp.356-365, 2008. ,
Quality of life (QoL) as predictive mediator variable for survival in patients with intracerebral neoplasma during radiotherapy, Onkologie, vol.26, pp.38-43, 2003. ,
The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD, Chest, vol.126, pp.81-89, 2004. ,
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma, Ann Oncol, vol.17, pp.1083-1089, 2006. ,
A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients, Schizophr Res, vol.77, pp.99-104, 2005. ,
Cost of relapse in schizophrenia, Schizophr Bull, vol.21, pp.419-429, 1995. ,
The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study, Soc Psychiatry Psychiatr Epidemiol, vol.40, pp.707-717, 2005. ,
, Diagnostic and Statistical Manual of Mental Disorders, 1994.
Significance of positive and negative syndromes in chronic schizophrenia, Br J Psychiatry, vol.149, pp.439-448, 1986. ,
The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance, Arch Gen Psychiatry, vol.33, pp.766-771, 1976. ,
A rating scale for extrapyramidal side effects, Acta Psychiatr Scand Suppl, issue.212, pp.11-19, 1970. ,
A rating scale for drug-induced akathisia, Br J Psychiatry, vol.154, pp.672-676, 1989. ,
Assessment of tardive dyskinesia using the Abnormal Involuntary Movement Scale, J Nerv Ment Dis, vol.173, pp.353-357, 1985. ,
Rating of medication influences (ROMI) scale in schizophrenia, Schizophr Bull, vol.20, pp.297-310, 1994. ,
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection, Med Care, vol.30, pp.473-483, 1992. ,
A quality of life interview for the chronically mentally ill, Eval Program Plann, vol.11, issue.1, pp.51-62, 1988. ,
What is relapse in schizophrenia?, Int Clin Psychopharmacol, vol.9, issue.5, pp.5-9, 1995. ,
Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials, Am J Psychiatry, vol.160, pp.1209-1222, 2003. ,
Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia, Schizophr Bull, vol.26, pp.659-666, 2000. ,
Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments, Eur Psychiatry, vol.20, pp.510-519, 2005. ,
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level, World Psychiatry, vol.10, pp.138-151, 2011. ,
Management of physical health in schizophrenia: a stepping stone to treatment success, Eur Neuropsychopharmacol, vol.18, issue.2, pp.121-128, 2008. ,
Sociodemographic and clinical factors associated with relapse in schizophrenia, Psychiatry Clin Neurosci, vol.61, pp.587-593, 2007. ,
The relation between objective and subjective domains of recovery among persons with schizophreniarelated disorders, Schizophr Res, vol.131, pp.133-138, 2011. ,
A scientific agenda for the concept of recovery as it applies to schizophrenia, Clin Psychol Rev, vol.28, pp.1108-1124, 2008. ,
Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia, Psychiatry Res, vol.202, issue.2, pp.155-160, 2012. ,
Metacognition and social function in schizophrenia: associations over a period of five months, Cogn Neuropsychiatry, vol.16, pp.241-255, 2011. ,
Addressing metacognitive capacity for self reflection in the psychotherapy for schizophrenia: a conceptual model of the key tasks and processes, Psychol Psychother, 2010. ,
Relapse: a reappraisal of assessment of outcome in schizophrenia, Schizophr Bull, vol.10, pp.293-299, 1984. ,
Predicting relapse after a first episode of non-affective psychosis: a three-year follow-up study, J Psychiatr Res, vol.2012, issue.8, pp.1099-1105 ,
Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year, Br J Psychiatry, vol.187, pp.131-136, 2005. ,
How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review, Value Health, vol.14, pp.907-920, 2011. ,
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness, J Clin Psychiatry, vol.70, issue.4, pp.47-48, 2009. ,
Intervention research in psychosis: issues related to the assessment of quality of life, Schizophr Bull, vol.26, pp.557-564, 2000. ,
Psychiatrists in the UK do not use outcomes measures. National survey, Br J Psychiatry, vol.180, pp.101-103, 2002. ,
The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory?, Soc Sci Med, vol.60, pp.833-843, 2005. ,
The lack of impact of quality-of-life measures in schizophrenia: a shared responsibility, Pharmacoeconomics, vol.2012, issue.6, pp.531-533 ,
Quality of life is predictive of relapse in schizophrenia, BMC Psychiatry, vol.13, p.15, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02651161